Dr. Meagan Elizabeth Gray, MD

Dr. Gray practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Gray's NPI, 1457613580, was assigned on June 14, 2012. Dr. Gray graduated from University of Louisville School of Medicine in 2012. Dr. Gray holds Alabama license 36749.

Dr. Gray's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Gray's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Gray is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Gray to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gray practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gray's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gray is licensed in Alabama.

CMS data shows 519 Medicare services from Dr. Gray across 13 procedure codes in 2024, for 265 Medicare patients. Medicare paid $31,020 for them.

CMS counts 265 Medicare patients who saw Dr. Gray in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gray's median patient age at 60, with 56% women.

In 2024, Dr. Gray wrote 1,088 Medicare Part D claims for 232 patients. 74% of them were for generic drugs. CMS names the drug for 910 of them, across 24 drugs with 11 or more claims each, at $486,774 in total drug cost. In 2023, CMS named 1,042 claims across 28 drugs.

Dr. Gray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gray, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Gray, published from 2013 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Non-alcoholic Fatty Liver Disease, Liver and Liver Cirrhosis. Dr. Gray has published most often in J Investig Med High Impact Case Rep. Dr. Gray's most frequent co-authors are Nancy L. Ascher, MD, Robert M. Centor, MD and Kenneth Cusi, MD.

Dmand AI links Dr. Gray to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Esophageal and Gastric Varices, Non-alcoholic Fatty Liver Disease and Fatty Liver. Open Payments lists research payments to Dr. Gray that name 1 trial.

CMS Open Payments shows 101 general payments to Dr. Gray from 16 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 91% of the total. Novo Nordisk Inc paid the most, $79,417. It also lists 3 research payments totaling $1,164 from 2021 to 2023, naming 1 clinical trial.

Dr. Gray graduated from University of Louisville School of Medicine in 2012.